Knowledge on nuclear transfer technologies for preventing mitochondrial diseases has opened a new line of research for these techniques in infertile patients with poor oocyte quality. Thus, the technique is not offered to patients anymore, as it is an invasive procedure requiring a laparoscopy for obtaining the sample of ovarian cortex. Results showed no benefit in terms of live birth rate, embryo grading or euploid status. An intrapatient comparison was done and oocytes were randomized to receive the experimental technique ( Augment) or conventional ICSI.
Fifty-nine infertile patients aged 42 or less with background of unsuccessful IVF and evidence of bad embryo quality were included.
#Ivi rma innovation trial
Some babies were born in Canada, United Emirates and Turkey, but the technique had been offered as the last chance to these patients before having performed a proper study analyzing its impact.įor this reason, an experimental randomized trial was performed in IVI RMA Valencia, Spain, headed by Dr. Controversy came because the finding of these egg precursor cells could not be replicated in other laboratories. The advantage was the avoidance of heteroplasmy in the oocyte. In 2014, a technique consisting of injecting autologous mitochondria resident in “egg precursor cells” (present in the ovarian cortex) into the egg of the infertile patient during the ICSI procedure was launched (the so-called Augment technique, from OvaScience). Several approaches have been proposed to overcome this problem.Ĭytoplasmic transfer from young oocytes to the oocytes of older women with a history of reproductive failure showed to improve embryo development and delivery of live offspring, but this technique performed in the 90’s was abandoned because of the risk of mitochondrial heteroplasmy (presence of mitochondria from two different sources) and some cases of aneuploidy reported. Maternal age is negatively correlated with the oocyte mitochondrial DNA (mtDNA) copy number, thus impairing processes of oocyte maturation, especially nuclear spindle activity and chromosomal segregation. The oocyte has the largest number of mitochondria and mitochondrial DNA copies of any cell. In fact, they play a vital role in most cell functions by providing a steady source of adenosine trisphosphate (ATP) through oxidative phosphorylation (OXPHOS). Mitochondria can be considered the factory of energy in the cells. One important factor is the mitochondrial dysfunction that has been shown in patients of advance maternal age.
Female fertility is one of the first physiological functions adversely affected by aging.
0 kommentar(er)
